DENVER--(BUSINESS WIRE)--Strive Health, a national leader in value-based kidney care, has raised $166 million in Series C funding. This funding round was led by NEA alongside five new investors, ...

Kidney care company Strive Health scored a whopping $166 million in Series C funding led by NEA alongside strategic investor CVS Health Ventures. Existing investors CapitalG (Alphabet), Town Hall ...

Regence is partnering with kidney care provider Strive Health on a care program for Medicare Advantage members with advanced chronic or end-stage kidney disease. The program aims to serve the 16,000 ...

Renowned nephrologist and quality of care advocate will lead clinical programs and provider teams in delivering evidence-based, patient-centered care Strive Health, the national leader in value-based ...

Prominence Health Plan is now working with Strive Health to offer additional kidney treatment to its members, the companies announced last week. Nevada-based Prominence Health Plan provides coverage ...

The value-based kidney care company currently manages nearly $5 billion of annual medical spend, and this funding allows it to further scale its business to support more patients and providers Strive ...

It’s widely known that healthcare is expensive in the United States and that patients are looking for better quality of care that is more cost-effective. That kind of care, called “value-based,” has ...

DENVER--(BUSINESS WIRE)--Denver-based Strive Health, the national leader in value-based kidney care, and Nevada-based Prominence Health Plan, which provides compassionate health coverage to commercial ...

The partnership will serve patients across the 21 states Oak Street Health has a footprint in. If an Oak Street Health patient has stage 4 chronic kidney disease or end-stage kidney disease, they’ll ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Strive Health raised $166 million in Series C funding ...